TLY — Totally Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Totally, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	78	106	114	127	136
Cost of Revenue
Gross Profit	12.1	19.2	20.8	22.9	25
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	79.6	109	113	126	134
Operating Profit	-1.59	-3.11	0.244	1.47	2.08
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1.81	-3.41	0.056	1.26	1.78
Provision for Income Taxes
Net Income After Taxes	-1.5	-2.83	0.318	1.08	1.78
Net Income Before Extraordinary Items
Net Income	-1.5	-2.83	0.318	1.08	1.78
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1.5	-2.83	0.318	1.08	1.78
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.02	-0.006	0.002	0.007	0.013
Dividends per Share